Bengaluru-based instant medicine delivery startup Plazza has raised $15 million in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners, as investors continue to back specialized quick-commerce platforms beyond groceries. Existing investors All In Capital and Better Capital also participated in the round, underscoring confidence in Plazza’s pharmacy-first delivery model.
The fresh capital will be used to expand Plazza’s store network, strengthen its AI-powered inventory management platform, enhance operational capabilities, and enter new markets. Founded in 2024 by former Zomato executive Aman Priyadarshi, the startup promises medicine deliveries within 15 to 30 minutes, positioning itself as a quick-commerce platform focused exclusively on healthcare.
Plazza Secures $15 Million to Scale Rapid Medicine Delivery
The Series A funding marks a significant milestone for the young startup, coming less than a year after it raised $1.4 million in seed funding.
The investment was led by:
- Accel
- Elevation Capital
- Nexus Venture Partners
Existing backers:
- All In Capital
- Better Capital
also participated in the round, reflecting continued investor confidence in Plazza’s growth trajectory.
Funding Overview
| Item | Details |
|---|---|
| Funding round | Series A |
| Amount raised | $15 million |
| Lead investors | Accel, Elevation Capital, Nexus Venture Partners |
| Existing investors | All In Capital, Better Capital |
| Founded | 2024 |
| Founder | Aman Priyadarshi |
AI-Powered Pharmacy Model Drives Differentiation
Unlike traditional e-pharmacies, Plazza operates a pharmacy-first quick-commerce model built around neighborhood fulfillment centers with significantly deeper inventory.
The startup says each store stocks:
- More than 40,000 SKUs.
- Around eight times the inventory of a typical neighborhood pharmacy.
- Prescription fill rates exceeding 95%, compared with the industry average of 50–60%.
Its AI-powered inventory planning system analyzes neighborhood demand patterns to optimize medicine availability while reducing stock-outs.
Business Model Highlights
| Feature | Details |
|---|---|
| Delivery time | 15–30 minutes |
| Inventory per store | 40,000+ SKUs |
| Technology | AI-powered inventory planning |
| Prescription fill rate | Over 95% |
| Focus | Pharmacy-first quick commerce |
Capital to Fuel Expansion
Plazza plans to use the new funding to accelerate growth across several areas.
Key investment priorities include:
- Expanding its pharmacy store network.
- Strengthening AI-driven inventory and assortment intelligence.
- Enhancing its technology platform.
- Building operational capabilities.
- Entering additional cities and geographies.
The company is reportedly targeting rapid physical expansion as it scales its inventory-led fulfillment model to serve more urban markets.
Planned Use of Funds
| Investment Area | Objective |
|---|---|
| Store expansion | Increase delivery coverage |
| AI technology | Improve inventory optimization |
| Operations | Scale fulfillment capabilities |
| Market expansion | Enter new cities |
Strong Early Growth Attracts Investors
Plazza says its business has grown rapidly since launch.
According to the company:
- Gross merchandise value (GMV) increased nearly 27 times between June 2025 and March 2026.
- Repeat customers place shopping baskets roughly 30% larger than first-time users.
These metrics have helped position Plazza as one of India’s emerging quick-commerce startups focused on healthcare rather than groceries.
Growth Metrics
| Metric | Performance |
|---|---|
| GMV growth | Nearly 27× (June 2025–March 2026) |
| Repeat customer basket size | About 30% larger than first-time customers |
| Delivery promise | 15–30 minutes |
Competition Intensifies in Digital Healthcare
The funding comes as competition in online pharmacy and healthcare quick commerce accelerates.
Major players are investing heavily in faster medicine delivery, while startups are differentiating themselves through inventory depth, AI-driven logistics, and hyperlocal fulfillment.
For Plazza, combining rapid delivery with high medicine availability could help it compete against larger e-pharmacy and quick-commerce platforms seeking to expand into healthcare.
Competitive Position
| Strength | Competitive Advantage |
|---|---|
| Deep inventory | Higher medicine availability |
| AI-powered planning | Better demand forecasting |
| Quick fulfillment | 15–30 minute delivery |
| Pharmacy-first model | Specialized healthcare focus |
Looking Ahead
Plazza’s $15 million Series A funding marks another sign of investor confidence in India’s evolving healthcare and quick-commerce ecosystem. By combining AI-powered inventory management with an inventory-led pharmacy network, the startup is aiming to solve one of the biggest challenges in medicine delivery—ensuring the right medicines are available when customers need them.
As the company expands its store footprint and enters new markets, its ability to maintain high prescription fill rates while scaling operations will be key. With specialized healthcare delivery emerging as a fast-growing segment within India’s quick-commerce landscape, Plazza’s latest funding positions it to compete more aggressively with both established e-pharmacy players and diversified quick-commerce platforms.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
